5 Autoimmune Conditions Indian Women Are Diagnosed With Too Late, And What Delays The Diagnosis

A 2019 study published in Lupus Science & Medicine found that the average diagnostic delay for SLE in South Asian women was 4.7 years from first symptom to confirmed diagnosis. In India, that delay is compounded by the fact that the butterfly rash, the most photographed lupus symptom in Western textbooks, presents differently on deeper skin tones and is frequently missed or attributed to sun exposure. Joint pain gets filed under general body ache. Fatigue gets attributed to anaemia, which lupus itself can cause, creating a loop where the symptom and its misread cause chase each other for years.
Lupus is nine times more common in women than men. The antibody test that confirms it, the ANA (antinuclear antibody) panel, is not part of routine blood work at most government hospitals and many private clinics outside metro cities. Women in tier-2 and tier-3 towns are frequently referred to dermatologists for the rash and to orthopaedicians for the joints, with nobody connecting the two presentations as a single systemic disease.
What delays it further: lupus flares and remits. A woman who had debilitating joint pain for six weeks may feel fine by the time she gets a specialist appointment. Doctors who see her in remission find little to investigate. The cycle repeats.Hashimoto's is the most common autoimmune condition in Indian women and also the most under-diagnosed as an autoimmune disease specifically. Most women who have it are told they have hypothyroidism, started on levothyroxine, and sent home. That treatment manages the thyroid hormone deficit. It does not address the immune attack on the thyroid gland, which continues.
The distinction matters because Hashimoto's carries a higher risk of other autoimmune conditions, rheumatoid arthritis, lupus, type 1 diabetes, and women who know they have it can be monitored accordingly. The test that identifies it, the anti-TPO antibody test, costs under Rs 500 at most diagnostic labs. It is ordered far less often than it should be.

A 2020 study in the Indian Journal of Endocrinology and Metabolism found that anti-TPO antibodies were present in 38% of women presenting with hypothyroidism in a North Indian cohort, meaning a significant proportion of women being treated for a thyroid disorder had an underlying autoimmune condition that was never formally identified.Rheumatoid arthritis is frequently misread as osteoarthritis in Indian women over 35, partly because of how the two are discussed in popular health communication and partly because morning stiffness, the hallmark RA symptom, is normalised as a sign of ageing. The stiffness that lasts more than an hour after waking, that eases with movement but returns, is not the stiffness of a worn joint. It is inflammation driven by the immune system attacking synovial tissue.
The diagnostic gap here has a specific consequence. RA caught within the first year of symptoms responds significantly better to disease-modifying antirheumatic drugs (DMARDs) than RA caught after joint damage has already occurred. A 2018 paper in the Indian Journal of Rheumatology documented that the median delay from symptom onset to rheumatologist referral in Indian women was 24 months. Two years. By that point, erosive joint damage is often already visible on X-ray.

The referral pathway is part of the problem. Women with joint pain in India typically see a general physician first, then an orthopaedic surgeon. Rheumatologists, who are the appropriate specialists for RA, are a small and unevenly distributed specialty. There are fewer than 1,000 practicing rheumatologists in the country for a population of over a billion.Sjögren's presents primarily as dry eyes and dry mouth, which is why it takes an average of nearly seven years to diagnose globally, and longer in India, where the condition has low clinical awareness outside major teaching hospitals. Women with Sjögren's are frequently told they are dehydrated, or that they are spending too much time in air conditioning, or that the dry eyes are a screen-time problem. All of these are plausible explanations for the symptoms. None of them are the cause.
Sjögren's can exist on its own (primary) or alongside lupus or rheumatoid arthritis (secondary). In women who already carry one of those diagnoses, Sjögren's symptoms are sometimes assumed to be part of the existing condition rather than a co-occurring one. The specific antibodies that confirm Sjögren's, anti-SSA and anti-SSB, are tested for only when a clinician is already thinking about the diagnosis. That thinking rarely happens early.Antiphospholipid syndrome (APS) causes the blood to clot abnormally and is a leading cause of recurrent miscarriage. In Indian women, it is most commonly encountered after the second or third pregnancy loss, at which point investigation finally begins. The first loss is attributed to chance. The second raises concern. The third triggers testing. By then, a woman has gone through two or three years of grief and repeated pregnancy failure for a condition that is diagnosable with a blood test and manageable with anticoagulants.

APS is also associated with stroke in young women, and young women who have strokes in India are not automatically screened for autoimmune causes. A 2021 review in Annals of Indian Academy of Neurology noted that antiphospholipid antibodies were identified in a meaningful proportion of young Indian women presenting with ischaemic stroke, a finding that points to systematic under-investigation at the point of acute care.
The pattern across all five conditions is the same: symptoms that are real, investigations that are available, and a gap in between that is filled by normalisation, misattribution, and a referral chain that was not designed with autoimmune disease in mind. Women who push for answers get them. Women who accept the first explanation often wait years. The immune system, when it turns on itself, does not wait with them.